Miriam Elman

Miriam Elman is a Senior Professor at Oregon Health & Science University, where her research bridges cardiology, public health, and critical care epidemiology. Her work focuses on structural heart disease, cardiomyopathy, and cardiovascular outcomes, with recent studies examining tafamidis efficacy in transthyretin amyloid cardiomyopathy and myocardial contraction fraction as a prognostic tool in the TOPCAT trial. She also investigates health policy and disparities, including trauma care for unhoused populations and community consent in pediatric prehospital trials. Her publications span leading journals such as JACC CardioOncology and the Journal of the American Heart Association, reflecting her commitment to translating clinical data into actionable health policy.